Effect of Antioxidant Vitamins on the Oxidant / Antioxidant Status in Patients with Multiple Sclerosis

Dr. Wahda B. Al-Youzbaki

Authors

Dr. Wahda B. Al-Youzbaki

Keywords:

multiple sclerosis, malondialdehyde, ascorbic acid, tocopherol

Abstract

Abstract not found

Downloads

How to Cite

Effect of Antioxidant Vitamins on the Oxidant / Antioxidant Status in Patients with Multiple Sclerosis. (2014). Global Journal of Medical Research, 14(B1), 29-34. https://medicalresearchjournal.org/index.php/GJMR/article/view/520

Download Citation

References

P Kidd (2001) Multiple Sclerosis, an Autoimmune Inflammatory Disease: Prospects for its Integrative Management. 6(6).

A Hadzovic-Dzuvo, O Lepara, A Valjevac, N Avdagic, S Hasic, E Kiseljakovic (2011) Serum total antioxidant capacity in patients with multiple sclerosis. Bosnian Bas. 11(1), 33-36.

Barbara Tavazzi, Anna Batocchi, Angela Amorini, Viviana Nociti, Serafina D'urso, Salvatore Longo, Stefano Gullotta, Marika Picardi, Giuseppe Lazzarino (2011) Serum Metabolic Profile in Multiple Sclerosis Patients. 2011, 1-8.

G Acar (2003) Nitric oxide as an activity marker in multiple sclerosis. 250, 588-592.

E Miller, M Mrowicka, K Zołyński (2009) Oxidative stress in multiple sclerosis. 27(162), 499-502.

Fengmin Lu, Mary Selak, John O'connor, Sidney Croul, Carlos Lorenzana, Catalin Butunoi, Bernadette Kalman (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. 177(2), 95-103.

R Dutta, J Mcdonough, X Yin, J Peterson, A Chang, T Torres (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. 59, 478-489.

Don Mahad, Iryna Ziabreva, Hans Lassmann, Douglas Turnbull (2008) Mitochondrial defects in acute multiple sclerosis lesions. 131(7), 1722-1735.

Bruce Trapp, Peter Stys (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. 8(3), 280-291.

M Witte, J Geurts, He, P Van Der Valk, J Van Horssen (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration. 10, 411-418.

Sayonara Oliveira, Ana Kallaur, Andréa Simão, Helena Morimoto, Josiane Lopes, Carolina Panis, Diego Petenucci, Eloisa Da Silva, Rubens Cecchini, Damácio Kaimen-Maciel, Edna Reiche (2012) Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale. 321(1-2), 49-53.

Gavin Higgins, Philip Beart, Yea Shin, Minghui Chen, Nam Cheung, Phillip Nagley (2010) Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury. 20(s2), S453-S473.

Bernadette Kalman, Thomas Leist (2003) A Mitochondrial Component of Neurodegeneration in Multiple Sclerosis. 3(3), 147-158.

P Mao, H Reddy (2010) Is multiple sclerosis a mitochondrial disease?. 1802, 66-79.

Jack Van Horssen, Maarten Witte, Gerty Schreibelt, Helga De Vries (2011) Radical changes in multiple sclerosis pathogenesis. 1812(2), 141-150.

I Tasset, E Agüera, F Sanchez-Lopez, M Feijoo, A Giraldo, A Cruz (2012) Peripheral oxidative stress in relapsing-remitting multiple sclerosis. 45, 440-444.

Hans Lassmann, Jack Van Horssen (2011) The molecular basis of neurodegeneration in multiple sclerosis. 585(23), 3715-3723.

Didem Pekmezci (2011) Vitamin E and Immunity. 86, 179-215.

M Yilmaz, A Karakoc, N Caker, F Toruner, E Duzgun, I Yetkin (2004) The effect of vitamin E on oxidative stress and metabolic status in diabetes mellitus. 2, 200-205.

D Lee, R Gold, R Linker (2012) Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters. 13, 11783-11803.

S Spitsin, G Scott, T Mikheeva, A Zborek, R Kean, C Brimer (2002) Comparison of uric acid and ascorbic acid in protection against EAE. 33, 1363-1371.

A Tappel (1998) Will antioxidant nutrients slow aging processes?. 23, 97-105.

John Buege, Steven Aust (1978) [30] Microsomal lipid peroxidation. 52, 302-310.

John Kurtzke (1983) Rating neurologic impairment in multiple sclerosis. 33(11), 1444-1444.

R Naidoo, M Knapp (1992) Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. 38, 2449-2454.

V Calabrese, R Raffaele, E Cosentino, V Rizza (1994) Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. 14, 119-123.

Halit Besler, Selçuk Çomoğlu, Zek Okçu (2002) Serum Levels of Antioxidant Vitamins and Lipid Peroxidation in Multiple Sclerosis. 5(3), 215-220.

E Miller, M Mrowicka, J Saluk-Juszczak, M Ireneusz (2011) The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis. 36, 1012-1016.

Eszter Karg, Péter Klivényi, Ilona Németh, Krisztina Bencsik, Sándor Pintér, László Vécsei (1999) Nonenzymatic antioxidants of blood in multiple sclerosis. 246(7), 533-539.

S Vinychuk, G Donchenko, R Мorosova, O Kopchak, E Pasechnaya, S Silonov (2004) Prooxidant-antioxidant disbalance in multiple sclerosis and its role in the development of fatigue in patients. 44, 11-12.

M Koch, G Ramsaransing, A Arutjunyan, M Stepanov, A Teelken, D Heersema, J Keyser (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. 253(4), 483-487.

Halit Besler, Selçuk Çomogˇlu (2003) Lipoprotein Oxidation, Plasma Total Antioxidant Capacity and Homocysteine Level in Patients with Multiple Sclerosis. 6(3), 189-196.

G Ferretti, T Bacchetti, F Principi, F Di Ludovico, B Viti, V Angeleri, M Danni, L Provinciali (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. 11(6), 677-682.

N Carlson, J Rose (2006) Antioxidants in multiple sclerosis: do they have a role in therapy?. 6, 433-441.

J Van Horssen, G Schreibelt, J Drexhage, T Hazes, C Dijkstra, P Van Der Valk, H De Vries (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. 45(12), 1729-1737.

I-Y Choi, S-P Lee, D Denney, S Lynch (2011) Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by ¹H magnetic resonance chemical shift imaging at 3 T. 17(3), 289-296.

Elzbieta Miller, Malgorzata Mrowicka, Katarzyna Malinowska, Krystian Zolynski, Józef Kedziora (2010) Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study. 57(1,2), 168-173.

Felix Jiménez-Jiménez, Fernando De Bustos, José Molina, Clara De Andrés, Teresa Gasalla, Miguel Ortı́-Pareja, Martı́n Zurdo, Jesús Porta, Francisca Castellano-Millán, Joaquı́n Arenas, Rafael De Salamanca (1998) Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. 249(1), 65-67.

G Salemi, M Gueli, F Vitale, F Battaglieri, E Guglielmini, P Ragonese (2010) Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. 9(19), 1-3.

I Juranek, S Bezek (2005) Controversy of free radical hypothesis: reactive oxygen species-cause or consequence of tissue injury?. 24, 263-278.

G Geldern, E Mowry (2012) The influence of nutritional factors on the prognosis of multiple sclerosis. 8, 678-689.

Cinthia Mazzanti, Roselia Spanevello, Musthaq Ahmed, Luciane Pereira, Jamile Gonçalves, Maisa Corrêa, Roberta Schmatz, Naiara Stefanello, Daniela Leal, Alexandre Mazzanti, Adriano Ramos, Tessie Martins, Cristiane Danesi, Dominguita Graça, Vera Morsch, Maria Schetinger (2009) Pre‐treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents. 27(1), 73-80.

M Goudarzvand, M Javan, J Mirnajafi-Zadeh, S Mozafari, T Tiraihi, E Vitamins, D (2010) 3 Attenuate Demyelination and Potentiate Remyelination Processes of Hippo-campal Formation of Rats Following Local Injection of Ethidium Bromide. 30, 289-299.